The largest database of trusted experimental protocols

Cytoscint es

Manufactured by MP Biomedicals
Sourced in United States

CytoScint ES is a liquid scintillation cocktail designed for counting radioactive samples in cell culture and other biological applications. It is a ready-to-use, biodegradable, and environmentally-friendly solution that provides high counting efficiency and low background levels.

Automatically generated - may contain errors

6 protocols using cytoscint es

1

DNA Synthesis Assay in VSMC

Check if the same lab product or an alternative is used in the 5 most similar protocols
A10 VSMC were cultured in DMEM containing 10% FBS and 0.01 mg/ml gentamicin (Gibco, Burlington, ON, Canada) at 37°C with 95% air and 5% CO2. DNA synthesis in A10 VSMC was measured by [3H]‐thymidine incorporation into the DNA of the cells 13; cells were cultured in 12‐well plates. Before the experiments, cells were incubated in serum‐free DMEM for 20 hrs. Lysophosphatidic acid was added 10 min. after the addition of different inhibitors and after incubation for 4 hrs, 1 μCi [3H]‐thymidine was added. The reaction was terminated after 22 hrs by keeping the cell culture plates on the ice and removing the culture medium. The cells were washed three times with 1 ml HEPES buffer (mM/l: NaCl 145, KCl 4.5, CaCl2 1.0, MgSO4·7H2O 1.0, HEPES 10, glucose 5, bovine serum albumin 0.1%, KH2PO4 1.0, pH 7.4). These cells were then incubated for 1 hr in cold 5% trichloroacetic acid on the ice, washed two more times with 0.5 ml HEPES buffer, and incubated with 0.2 ml NaOH (0.5 N) for 1 hr. The aliquots were transferred to scintillation vial. The radioactivity was counted in a Beckman LS 6500 scintillation counter after the addition of 10 ml Cytoscint‐ES (MP Biomedicals, Santa Ana, CA, USA).
+ Open protocol
+ Expand
2

Sodium-Dependent Glutamate Transport Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sodium-dependent transport of L-[3H]-glutamate was measured as previously described (Robinson et al. 1991 (link); Whitelaw and Robinson 2013 (link)). HKII or control treated synaptosomes (10 µL, containing ~40 µg of protein) were incubated with 0.5 µM L-[3H]-glutamate (PerkinElmer, Waltham, MA USA) in uptake buffer, containing 5 mM Tris base, 10 mM HEPES, 140 mM NaCl, 2.5 mM KCl, 1.2 mM CaCl2, 1.2 mM MgCl2, 1.2 mM K2HPO4, 10 mM glucose (pH=7.2) at 37°C for 3 min. We have previously determined that 3H-glutamate uptake is linear until at least 5 min in this system (Robinson 1991 (link)). Uptake was measured in the absence and presence of sodium by substituting equimolar amounts of choline chloride for NaCl. The assay was terminated by the addition of 2 ml of ice-cold choline-containing buffer. Following termination, the suspensions were filtered onto glass filter paper (FP-100; Brandel, Gaithersburg, MD USA) using a Brandel cell harvester and rinsed three times with 2 ml of cold choline-containing buffer. Radioactivity was solubilized with 5 ml of Cytoscint ES (MP Biochemicals, Solon, OH USA) and measured using scintillation spectrometry (Beckman-Coulter Instruments LS 6500). Sodium dependent uptake was calculated as the difference between the signal in the sodium-containing buffer from the signal in the choline-containing buffer.
+ Open protocol
+ Expand
3

Radioligand Binding Assay for Receptor

Check if the same lab product or an alternative is used in the 5 most similar protocols
As previously reported,10 (link) competition binding studies were performed in the presence of a fixed concentration of [3H]RTX and various concentrations of competing ligands. The binding assay mixtures were handled in borosilicate tubes and contained DPBS (with Ca2+ and Mg2+), bovine serum albumin (0.25 mg/mL), [3H]RTX (100 pM), and various concentrations of the ligands for a total volume of 350 μL. Non-specific binding was determined in the presence of non-radioactive RTX (100 nM). The tubes were incubated for 60 min in a 37 °C water bath. The mixtures were then cooled on ice for approximately 10 min, after which bovine glycoprotein fraction VI (100 μL; 2 mg/mL) was added to reduce nonspecific binding. The ice-cold contents were then transferred to 1.5 mL centrifuge tubes for centrifugation. Membrane-bound RTX was separated from free RTX as well as the glycoprotein-bound RTX by pelleting the membranes in a Beckman (Coulter) Allegra 21R centrifuge for 15 min at 12,000 rpm. Radioactivity in the pellets and in an aliquot of each supernatant was determined by scintillation counting in the presence of Cytoscint E.S. (MP Biomedicals). Equilibrium binding parameters (Ki, Bmax, and cooperativity) were determined by fitting the Hill equation to the measured values.
+ Open protocol
+ Expand
4

GTPγS Binding Kinetics of G Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
GTPγS binding was initiated by the addition of 100 mL of a buffer containing 2.5 mM cold GTPγS and 3.5 nM [35S]GTPγS to equal volumes (100 mL) of 400 nM purified G protein in 20 mM HEPES pH 7.7, 100 mM NaCl, 10 mM MgCl2, 14.3 mM β-ME, for a final assay concentration of 200 nM G protein. At specific time points (0, 3, 6, 10, 16, 22, 30 and 40 min) a 20 mL aliquot was withdrawn from the reaction and quenched in 100 μL ice-cold quenching buffer (20 mM HEPES pH 7.7, 100 mM NaCl, 10 mM MgCl2, 2 mM β-ME and 100 mM GTP). Quenched samples were immediately vacuum-filtered through PROTRAN BA-83 0.22 mm nitrocellulose filters (Whatman) presoaked in assay buffer containing 20 mM HEPES pH 7.7, 100 mM NaCl, 10 mM MgCl2, 14.3 mM β-ME and 1 mM GDP. Filters were washed twice with 4 mL of a buffer containing 20 mM HEPES pH 7.7, 100 mM NaCl and 2 mM MgCl2 and dried at room temperature overnight. Dried filters were transferred to scintillation vials containing 5 mL of liquid scintillation cocktail (CytoScint ES, MP Biomedicals). After 1 hour of equilibration the radioactivity was determined using a LS 6000IC Beckman counter. Association rate constants were determined by fitting the data to a single exponential using Prism 6 (GraphPad LLC, CA, RRID:SCR_002798).
+ Open protocol
+ Expand
5

Measuring Tracer Leakage in Brain Tumor Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
The day after post-treatment dynamic MRI, rats received 12.5 μCi of 14C-AIB (MW = 103 Da; American Radiolabeled Chemicals, St. Louis MO, USA) administered IV for assessment of unidirectional tracer leakage from the blood to brain tissue. A serum sample was collected 10 min after AIB administration followed by perfusion to clear the vasculature. The brains were harvested and four regions were dissected: tumor mass, tissue 1–2 mm brain around tumor (BAT), tissue 1–2 mm ipsilateral brain distant to tumor (BDT), and contralateral left hemisphere (LH) normal brain tissue. Each tissue sample was weighed, solubilized in 2 ml of sodium hydroxide overnight (MP Biomedicals, Solon, OH, USA) and radioactivity was determined by liquid scintillation counting in 20 ml of CytoScint ES (MP Biomedicals, Solon, OH, USA). Results were measured as percent injected dose normalized to 1 g of tissue.
+ Open protocol
+ Expand
6

Curcumin-Lidocaine Topical Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
All solvents (HPLC grade) were purchased from Fisher Scientific (Ottawa, ON). Curcumin, lidocaine, amphoterecin B, Tyrode's salts and glutaraldehyde solutions were purchased from Sigma Aldrich (St.Louis, MO,USA). The drugs docetaxel (DTX) and paclitaxel (PTX) were obtained from PolymedT Therapeutics (Houston, Tx, USA). Tritium-labeled DTX ( 3 H DTX) or PTX ( 3 H PTX) in ethanol was purchased from Moravek Biochemicals (Brea, CA, USA). Liquid scintillation fluid, CytoScint™-ES, was bought from MP Biomedicals (Irvine, CA, USA). Sodium cacodylate, and formaldehyde solutions (16%) were obtained from Canemco Inc. (Lakefield, QC, Canada). Control vehicles for dermal delivery were Glaxal Base Moisturizing Cream (WellSpring, GlaxalBase, ON, Canada) and PloGEL (Premium Lecithin Organogel, Transderma Pharmaceuticals Inc. Coquitlam, BC, Canada) and Labrasol (Gattefosse, Etobicoke ON, Canada). The pastes for perivesicular experiments were manufactured as previously reported 6 using 75% polymeric paste (60:40, MePEG: triblock copolymer), 20% EGCG or tannic acid and 5% dtx.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!